Omnicell (OMCL) Deferred Taxes (2010 - 2026)
Omnicell's (OMCL) quarterly Deferred Taxes came in at $6.7 million in Q2 2026, up 292.55% year-over-year from $1.7 million in Q2 2025, and up 58.21% quarter-over-quarter from $4.2 million in Q1 2026.
Analysis
Omnicell (OMCL) Deferred Taxes (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Deferred Taxes for 17 consecutive years, with $6.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Deferred Taxes rose 292.55% year-over-year to $6.7 million in Q2 2026; TTM through Jun 2026 was $11.8 million, a 230.06% increase from a year earlier, with the FY2025 full-year figure at -$1.3 million, up 91.3% from the prior year.
- Deferred Taxes was $6.7 million for Q2 2026 at Omnicell, up from $4.2 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $6.7 million in Q2 2026 and troughed at -$20.3 million in Q4 2022.
- A 5-year average of -$3.0 million and a median of -$3.3 million in 2023 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes sank 575.46% in 2022 and jumped 331.52% in 2025, its largest moves.
- Over 5 years, Deferred Taxes stood at -$20.3 million in 2022, then surged by 115.39% to $3.1 million in 2023, then plunged by 274.92% to -$5.5 million in 2024, then jumped by 53.69% to -$2.5 million in 2025, then surged by 364.81% to $6.7 million in 2026.
- The last three Deferred Taxes figures came in at $6.7 million (Q2 2026), $4.2 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -300,000.00 |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | - |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 6.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | 3.36 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | -3.84 Mn |
| Dec 31, 2024 | -5.45 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Jun 30, 2024 | -3.34 Mn |
| Mar 31, 2024 | -4.61 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Sep 30, 2023 | -3.15 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Mar 31, 2023 | -7.77 Mn |
| Dec 31, 2022 | -20.26 Mn |
| Sep 30, 2022 | -7.56 Mn |
| Jun 30, 2022 | -4.65 Mn |
| Mar 31, 2022 | -4.86 Mn |
| Dec 31, 2021 | -5.31 Mn |
| Sep 30, 2021 | 1.59 Mn |